Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Cash Flow Reinvestment Rate
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting CN¥3.59 Million (capex CN¥3.59 Million ) from operating cash flow of CN¥294.76 Million. Explore 002424 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Guizhou Bailing Group Pharmaceutical Co Ltd across 15 annual periods. Also explore balance sheet size of Guizhou Bailing Group Pharmaceutical Co for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Guizhou Bailing Group Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002424 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥131.71 Million | CN¥748.72 Million | CN¥125.24 Million | ▼ -99.1% |
| 2024 | 20.46x | CN¥184.60 Million | CN¥9.02 Million | CN¥42.02 Million | ▲ +1892.6% |
| 2023 | 1.03x | CN¥129.16 Million | CN¥125.77 Million | CN¥104.12 Million | ▲ +245.6% |
| 2022 | 0.30x | CN¥149.20 Million | CN¥502.15 Million | CN¥68.45 Million | ▼ -83.6% |
| 2021 | 1.81x | CN¥587.80 Million | CN¥324.92 Million | CN¥425.73 Million | ▲ +318.8% |
| 2020 | 0.43x | CN¥100.12 Million | CN¥231.78 Million | CN¥90.02 Million | ▼ -65.6% |
| 2019 | 1.26x | CN¥587.02 Million | CN¥467.41 Million | CN¥121.91 Million | ▼ -55.3% |
| 2017 | 2.81x | CN¥224.68 Million | CN¥79.88 Million | CN¥144.68 Million | ▲ +321.2% |
| 2016 | 0.67x | CN¥311.62 Million | CN¥466.62 Million | CN¥159.34 Million | ▲ +22.7% |
| 2015 | 0.54x | CN¥224.99 Million | CN¥413.23 Million | CN¥121.04 Million | ▲ +123.4% |
| 2014 | 0.24x | CN¥96.49 Million | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥88.74 Million | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥180.16 Million | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥193.07 Million | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥21.91 Million | CN¥125.31 Million | CN¥21.91 Million | — |